• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Lacerta Group Announces Acquisition of Portage Plastics Assets

SK Capital Partners

SK Capital Partners / January 9, 2023

Strategic acquisition will expand Lacerta’s production footprint into the Midwest to further enhance industry-leading customer service MANSFIELD, MA. – …

[Read more...] about Lacerta Group Announces Acquisition of Portage Plastics Assets

SK Capital Partners / January 3, 2023

New York, January 3, 2023 – SK Capital Partners, LP, a private investment firm focused on the specialty materials, specialty chemicals, and pharmaceuticals …

[Read more...] about SK Capital Announces Promotions

SK Capital Partners / December 1, 2022

Business to be Rebranded as Luxium Solutions Hiram, Ohio- December 1, 2022 – Funds advised by SK Capital Partners, LP (“SK Capital”) and Edgewater Capital …

[Read more...] about SK Capital Partners and Edgewater Capital Partners Close Acquisition of Crystals Business from Saint-Gobain

SK Capital Partners / October 5, 2022

The transaction fulfills IPACKCHEM’s vision of producing specialized barrier containers on every major continent for its multi-national customers Paris, …

[Read more...] about IPACKCHEM Acquires TPG Plastics LLC to Bring its Barrier Packaging to North America

SK Capital Partners / October 5, 2022

Baton Rouge, LA, October 4, 2022 —Deltech Holdings, LLC (“Deltech”), a leading producer of high-performance aromatic monomers, specialized crystal polystyrene, …

[Read more...] about Deltech Holdings Completes the Acquisition of StanChem

SK Capital Partners / September 28, 2022

Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability An affiliate of funds advised by SK …

[Read more...] about SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 18
  • ➞

Primary Sidebar

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login